Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
6 天
Medical Device Network on MSNEnable Injections’ syringe transfer system gains CE mark approvalEnable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...
7 天
GlobalData on MSNNewronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果